bioAffinity Technologies
BIAF
14 hedge funds and large institutions have $104K invested in bioAffinity Technologies in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 5 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
0.96% less ownership
Funds ownership: 3.29% → 2.32% (-0.96%)
7% less funds holding
Funds holding: 15 → 14 (-1)
21% less capital invested
Capital invested by funds: $132K → $104K (-$28.3K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AF
Allworth Financial
Folsom,
California
|
+$20.4K |
| 2 |
SG
StoneX Group
New York
|
+$5.83K |
| 3 |
IA
IFP Advisors
Tampa,
Florida
|
+$3.94K |
| 4 |
SI
Sprott Inc
Toronto,
Ontario, Canada
|
+$3.77K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.57K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$52K |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$5.87K |
| 3 |
VHAM
Van Hulzen Asset Management
El Dorado Hills,
California
|
-$4.16K |
| 4 |
HF
HRT Financial
New York
|
-$4K |
| 5 |
Barclays
London,
United Kingdom
|
-$827 |
BIAF Hedge Fund Activity: Q2 2025 in Review
14 of the 7,616 institutional investors tracked by Wall St. Rank reported a position in bioAffinity Technologies (BIAF) for Q2 2025, worth a combined $104K — down 21% from $132K a quarter earlier.
Fund positioning in BIAF was balanced in Q2 2025: 5 funds opened new positions, 5 closed out, 3 added to existing stakes and 1 trimmed.
The largest buyer was Allworth Financial, opening a new position worth an estimated $20.4K. The largest seller was Vanguard Group, cutting an estimated $52K.
- 14 institutional investors held bioAffinity Technologies (BIAF) as of Q2 2025, down from 15 in Q1 2025.
- Funds reported $104K of bioAffinity Technologies stock for Q2 2025, down 21% quarter-over-quarter.
- 5 funds opened new bioAffinity Technologies positions in Q2 2025 and 5 closed out, a net change of 0 holders.
- The largest bioAffinity Technologies buyer in Q2 2025 was Allworth Financial, an estimated $20.4K added.
- The largest bioAffinity Technologies seller in Q2 2025 was Vanguard Group, an estimated $52K sold.
Based on aggregated 13F filings for Q2 2025.